Document is current

Article History

Received: 3 August 2023

Accepted: 13 October 2023

First Online: 25 October 2023

Change Date: 11 December 2023

Change Type: Update

Change Details: The original version of the Article contained a spelling error in the short summary. The first author’s name was incorrect and stated to be “Pallet”, but it should have been “Pallett”. This has now been corrected in the HTML

Competing interests

: The authors declare the following competing interests: S.E.B. holds the Young Scientist Seat for the British Society for Antimicrobial Chemotherapy Antimicrobial Susceptibility Testing Committee. S.E.B. has consulted for bioMerieux and Sumitovant, received speaker fees from Shionogi and the UK Clinical Pharmacy Association, and was supported by a research grant obtained through a Medical Research Council (MRC)-awarded UK Research and Innovation Fellowship within the North West England MRC Scheme in Clinical Pharmacology with support from Roche Pharma (2017–21). D.R.J. is the President of the British Society for Antimicrobial Chemotherapy. E.J.H. is the Defence Consultant Advisor for UK Defence Medical Services Pathology. S.J.C.P. has received a research grant from the Scientific Exploration Society. All other authors have no conflicts of interest to declare.